News
Stay up to date on NKGen Biotech’s company news and announcements.
NKGen Biotech, Inc.
Corporate Office
19700 Fairchild Rd, Suite #300
Irvine, CA 92612
GMP Facility
3001 Daimler Street
Santa Ana, CA 92705
Press Releases
2022
2021
2020
2019
NKGen Biotech Events
Check back soon for upcoming events!
NKGen on Social Media
Follow NKGen on social media to keep up-to-date on the latest company news and the science of Natural Killer cells!
NKGen Biotech Announces Collaboration with the Parkinson’s Foundation to Bring Its Novel Natural Killer Cell Therapy to the Clinic for Advanced Parkinson’s Disease
NKGen Biotech Receives IND Clearance from FDA for SNK02 Allogeneic Natural Killer Cell Therapy for Solid Tumors
NKGen Biotech Announces Publication in Journal of Cancer Research and Cellular Therapeutics on Durable Response for SNK01 in Advanced Sarcoma
NKGen Biotech to Present at the Baird 2022 Global Healthcare Conference
NKGen Biotech To Present SNK01 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2022
Yong Ben, M.D. Joins NKGen Biotech as Scientific and Clinical Advisor
NKGen Biotech Announces Appointment of Jill M. Jene, PhD as Chief Business Officer
NKGen Biotech to Participate in Truist Securities Cell Therapy Symposium
NKGen Biotech To Present SNK01 Clinical Data at the 2022 ASCO Annual Meeting
NKGen Biotech to Present at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting
NKGen Biotech Announces Three SNK01 Abstracts to be Presented at the 2022 ASCO Annual Meeting